JJeff Ryckman@jryckman3Score6060ARION adds to the negative IO+CRT story in esophageal cancer. Durvalumab + FOLFOX/50 Gy in 25 fx: PFS HR 0.91 (95% CI 0.55-1.49), OS HR 0.99. Only 112 pts, mostly SCC. No demons…Same topic ARION · 2 peopledurvalumabHeat 00 likes0 replies0 reposts
KKrishan Jethwa@KrishanJethwaScore6060🚨ARION PRODIGE 67🚨 Locally Advanced Esophagus Cancer (adeno or squam) n=112 Randomized CRT (50 Gy/25 Fx + FOLFOX) +/- concurrent and adjuvant durvalumab (total 12 m) No SS diffe…Same topic ARION · 2 peopledurvalumabHeat 00 likes0 replies0 reposts
